-
1 Comment
Beijing Strong Biotechnologies, Inc is currently in a long term downtrend where the price is trading 2.0% below its 200 day moving average.
From a valuation standpoint, the stock is 25.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.1.
Beijing Strong Biotechnologies, Inc's total revenue sank by 2.9% to $262M since the same quarter in the previous year.
Its net income has dropped by 53.1% to $53M since the same quarter in the previous year.
Finally, its free cash flow fell by 56.8% to $32M since the same quarter in the previous year.
Based on the above factors, Beijing Strong Biotechnologies, Inc gets an overall score of 0/5.
| ISIN | CNE100001Y26 |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Beta | 0.47 |
|---|---|
| PE Ratio | 16.24 |
| Target Price | 23.15 |
| Dividend Yield | 2.7% |
| Market Cap | 9B |
Beijing Strong Biotechnologies,Inc. provides in-vitro diagnostics products and services in the People's Republic of China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activated partial thromboplastin time, thrombin time, and fibrinogen, as well as antithrombin III, von Willebrand factor antigen, protein s activity, protein c, lupus anticoagulant, fibrin degradation products, and d-dimer. It also provides blood grouping card comprising ABO blood type anti stereotype detection card, DiaClon ABD-confirmation, and DiaClon ABO/D+ reverse grouping for patients; automatic coagulation analyzer, automatic biochemistry analyzer, and automated blood groupings analyzer; and SARS RBD neutralization antibody, SARS total antibody, SARS COV-2 antigen test kit for self testing, and SARS antigen card. In addition, the company provides technology and document services. It sells its products under the GCELL and Beijing MDC brands. The company was founded in 2001 and is headquartered in Beijing, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300406.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
